Annat Raiter

616 total citations
33 papers, 499 citations indexed

About

Annat Raiter is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Annat Raiter has authored 33 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Cell Biology. Recurrent topics in Annat Raiter's work include Endoplasmic Reticulum Stress and Disease (10 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Annat Raiter is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (10 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Annat Raiter collaborates with scholars based in Israel and Belgium. Annat Raiter's co-authors include Britta Hardy, Rinat Yerushalmi, Alexander Battler, Chana Weiss, Yaron Niv, Boris Kaplan, Abraham Novogrodsky, Riva Kovjazin, Ido Lubin and Olga Dratviman‐Storobinsky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Annat Raiter

33 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annat Raiter Israel 15 238 179 137 79 75 33 499
Ashfaq A. Parkar United States 9 294 1.2× 262 1.5× 78 0.6× 78 1.0× 53 0.7× 12 612
Eda Machado United States 10 428 1.8× 149 0.8× 179 1.3× 89 1.1× 44 0.6× 12 731
Luca De Maso Italy 10 178 0.7× 81 0.5× 141 1.0× 44 0.6× 59 0.8× 16 464
Christi Parham United States 12 153 0.6× 91 0.5× 242 1.8× 132 1.7× 47 0.6× 14 645
Shannon M. Ruppert United States 11 160 0.7× 153 0.9× 67 0.5× 33 0.4× 25 0.3× 15 384
Atsushi Terunuma United States 12 398 1.7× 96 0.5× 75 0.5× 120 1.5× 39 0.5× 23 659
Thomas Grussenmeyer Germany 15 360 1.5× 59 0.3× 201 1.5× 166 2.1× 61 0.8× 29 690
Guenther Eissner Germany 8 424 1.8× 107 0.6× 210 1.5× 87 1.1× 25 0.3× 14 586
H Iioka Japan 12 504 2.1× 160 0.9× 61 0.4× 104 1.3× 20 0.3× 43 704
Salim Abdisalaam United States 12 341 1.4× 48 0.3× 113 0.8× 144 1.8× 21 0.3× 13 527

Countries citing papers authored by Annat Raiter

Since Specialization
Citations

This map shows the geographic impact of Annat Raiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annat Raiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annat Raiter more than expected).

Fields of papers citing papers by Annat Raiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annat Raiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annat Raiter. The network helps show where Annat Raiter may publish in the future.

Co-authorship network of co-authors of Annat Raiter

This figure shows the co-authorship network connecting the top 25 collaborators of Annat Raiter. A scholar is included among the top collaborators of Annat Raiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annat Raiter. Annat Raiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alvarez‐Elizondo, Martha B., Annat Raiter, Rinat Yerushalmi, & Daphne Weihs. (2025). Chemotherapy-Induced Cell-Surface GRP78 Expression as a Prognostic Marker for Invasiveness of Metastatic Triple-Negative Breast Cancer. Annals of Biomedical Engineering. 53(4). 881–890. 1 indexed citations
2.
Raiter, Annat, Yael Barhum, Sharona Elgavish, et al.. (2024). Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function. Neoplasia. 60. 101117–101117. 1 indexed citations
3.
Alon, Danny, et al.. (2021). Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide. Frontiers in Medicine. 8. 675963–675963. 4 indexed citations
4.
5.
Raiter, Annat, et al.. (2020). Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1. Frontiers in Oncology. 10. 1500–1500. 15 indexed citations
6.
Hardy, Britta & Annat Raiter. (2013). New era in cancer immunotherapy: Twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors. Advances in Bioscience and Biotechnology. 4(4). 34–37. 1 indexed citations
7.
Hardy, Britta, et al.. (2012). Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity. Cellular Oncology. 35(5). 345–354. 26 indexed citations
8.
Goldenberg‐Cohen, Nitza, et al.. (2011). Peptide-binding GRP78 protects neurons from hypoxia-induced apoptosis. APOPTOSIS. 17(3). 278–288. 33 indexed citations
9.
Raiter, Annat, et al.. (2010). Angiogenic Peptides Improve Blood Flow and Promote Capillary Growth in a Diabetic and Ischaemic Mouse Model. European Journal of Vascular and Endovascular Surgery. 40(3). 381–388. 11 indexed citations
10.
Hardy, Britta & Annat Raiter. (2010). Peptide-binding heat shock protein GRP78 protects cardiomyocytes from hypoxia-induced apoptosis. Journal of Molecular Medicine. 88(11). 1157–1167. 31 indexed citations
11.
Raiter, Annat, et al.. (2010). Activation of GRP78 on Endothelial Cell Membranes by an ADAM15-Derived Peptide Induces Angiogenesis. Journal of Vascular Research. 47(5). 399–411. 33 indexed citations
12.
Damianovich, Maya, Miri Blank, Annat Raiter, Britta Hardy, & Yehuda Shoenfeld. (2009). Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg). International Immunology. 21(9). 1057–1063. 7 indexed citations
13.
Hardy, Britta, et al.. (2007). Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells. Biochemical Pharmacology. 75(4). 891–899. 40 indexed citations
14.
Hardy, Britta, Annat Raiter, Chana Weiss, et al.. (2006). Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions. Peptides. 28(3). 691–701. 23 indexed citations
15.
Hardy, Britta & Annat Raiter. (2005). A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody. Vaccine. 23(34). 4283–4291. 34 indexed citations
16.
Hardy, Britta, et al.. (2001). Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma. International Journal of Oncology. 19(5). 897–902. 9 indexed citations
17.
Raiter, Annat, et al.. (2001). Effect of exogenous thyroid‐stimulating hormone on thyroid papillary carcinoma cells in tissue culture. Head & Neck. 23(6). 479–483. 3 indexed citations
18.
Raiter, Annat, et al.. (2000). CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulation. International Immunology. 12(11). 1623–1628. 8 indexed citations
19.
Raiter, Annat. (1999). Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells. Immunology Letters. 69(2). 247–251. 16 indexed citations
20.
Hardy, Britta, et al.. (1997). Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: A comparative study. Human Antibodies. 8(2). 95–98. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashfaq A. Parkar Breakdown of academic impact, for papers by Eda Machado Breakdown of academic impact, for papers by Luca De Maso Breakdown of academic impact, for papers by Christi Parham Breakdown of academic impact, for papers by Shannon M. Ruppert Breakdown of academic impact, for papers by Atsushi Terunuma Breakdown of academic impact, for papers by Thomas Grussenmeyer Breakdown of academic impact, for papers by Guenther Eissner Breakdown of academic impact, for papers by H Iioka Breakdown of academic impact, for papers by Salim Abdisalaam
Rankless by CCL
2026